-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
summary
The effect of genetic variation on the overall burden of disease has not been fully assessed
main
Genome-wide association studies (GWASs) have identified thousands of variants
Past efforts in comparative risk assessment have included quantifying the impact of modifiable exposures (e.
An important indicator of the burden of disease is DALY
We propose a method to combine the genetic association results of 80 diseases from two biobank studies with DALY estimates from the 2019 GBD study 27 to outline the effects